tiprankstipranks
Anupam Rasayan India Ltd. (IN:ANURAS)
:ANURAS
India Market
Want to see IN:ANURAS full AI Analyst Report?

Anupam Rasayan India Ltd. (ANURAS) AI Stock Analysis

1 Followers

Top Page

IN:ANURAS

Anupam Rasayan India Ltd.

(ANURAS)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 5.2)
Rating:57Neutral
Price Target:
₹1,412.00
▲(6.35% Upside)
Action:Reiterated
Date:05/25/26
The score is primarily held back by weak cash generation (recurring negative free cash flow) and a very high P/E valuation. These are partially offset by improving revenue growth, still-solid profitability, and supportive technical trend signals with moderate momentum.
Positive Factors
Revenue Recovery & Profitability
A clear revenue rebound and sustained mid-20s EBITDA margin indicate demand resilience and operational leverage in core specialty chemicals lines. Over 2–6 months this supports durable earnings, helps maintain customer confidence on supply continuity, and underpins reinvestment into complex synthesis capabilities.
Negative Factors
Negative Free Cash Flow
Persistent negative free cash flow signals weak cash conversion despite accounting profits, implying reliance on external financing for capex and working-capital needs. Over months this limits financial flexibility, raises funding risk for growth projects, and can pressure credit metrics if not remediated.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Recovery & Profitability
A clear revenue rebound and sustained mid-20s EBITDA margin indicate demand resilience and operational leverage in core specialty chemicals lines. Over 2–6 months this supports durable earnings, helps maintain customer confidence on supply continuity, and underpins reinvestment into complex synthesis capabilities.
Read all positive factors

Anupam Rasayan India Ltd. (ANURAS) vs. iShares MSCI India ETF (INDA)

Anupam Rasayan India Ltd. Business Overview & Revenue Model

Company Description
Anupam Rasayan India Ltd., established in Surat, India, in 1984, specializes in the custom synthesis and production of specialty chemicals. The company manufactures a diverse range of life science-oriented chemicals, including intermediates and ac...
How the Company Makes Money
Anupam Rasayan primarily makes money by manufacturing and selling specialty chemical intermediates under a business-to-business (B2B) model. Its core revenue stream is contract/custom manufacturing (custom synthesis) where customers outsource the ...

Anupam Rasayan India Ltd. Financial Statement Overview

Summary
Revenue rebounded strongly in FY2026 (+12%), and profitability remains solid (gross margin ~34.5%, EBITDA margin ~22.2%), but margins are still below FY2022–FY2025 levels. Balance sheet is acceptable with moderate but rising leverage (debt-to-equity ~0.56). The main drag is weak cash conversion: free cash flow is negative in most years and worsened in FY2026 (~-3.6B), despite operating cash flow turning positive (~2.0B).
Income Statement
62
Positive
Balance Sheet
68
Positive
Cash Flow
34
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue21.11B23.65B14.42B14.80B16.02B10.74B
Gross Profit9.34B8.16B8.22B8.51B8.85B7.02B
EBITDA5.19B5.43B4.00B3.82B4.29B3.03B
Net Income1.51B1.70B933.49M1.29B1.81B1.52B
Balance Sheet
Total Assets56.50B80.13B52.69B46.02B37.78B28.91B
Cash, Cash Equivalents and Short-Term Investments4.44B4.11B1.35B3.48B6.67B618.77M
Total Debt12.23B18.67B13.73B10.70B8.22B8.36B
Total Liabilities22.01B33.83B21.87B16.71B12.70B11.64B
Stockholders Equity31.97B33.34B28.50B27.61B23.73B17.27B
Cash Flow
Free Cash Flow3.28B-3.57B-4.40B-6.57B713.03M-3.18B
Operating Cash Flow5.35B1.99B-301.25M590.32M2.92B-1.71B
Investing Cash Flow-2.53B-8.21B-3.30B-3.92B-5.23B-4.12B
Financing Cash Flow182.51M7.57B2.23B3.95B3.71B3.84B

Anupam Rasayan India Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1327.70
Price Trends
50DMA
1322.55
Negative
100DMA
1294.63
Negative
200DMA
1237.46
Positive
Market Momentum
MACD
-14.76
Negative
RSI
42.62
Neutral
STOCH
64.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ANURAS, the sentiment is Negative. The current price of 1327.7 is above the 20-day moving average (MA) of 1288.83, above the 50-day MA of 1322.55, and above the 200-day MA of 1237.46, indicating a neutral trend. The MACD of -14.76 indicates Negative momentum. The RSI at 42.62 is Neutral, neither overbought nor oversold. The STOCH value of 64.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ANURAS.

Anupam Rasayan India Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹75.97B38.281.37%-0.74%-14.12%
69
Neutral
₹87.53B48.420.62%-2.29%-3.26%
69
Neutral
₹143.49B43.790.15%22.01%75.16%
65
Neutral
₹88.71B19.970.67%11.88%17.67%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
₹143.82B83.790.06%64.44%77.60%
56
Neutral
₹96.96B34.580.74%5.04%11.10%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:ANURAS
Anupam Rasayan India Ltd.
1,263.30
119.60
10.46%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,711.35
-578.23
-25.25%
IN:GARFIBRES
Garware Technical Fibres Limited
765.35
-145.63
-15.99%
IN:JUBLINGREA
Jubilant Ingrevia Ltd.
608.75
-151.64
-19.94%
IN:PRIVISCL
Privi Speciality Chemicals Limited
3,673.20
1,411.96
62.44%
IN:TIMETECHNO
Time Technoplast Limited
179.70
-38.40
-17.61%

Anupam Rasayan India Ltd. Corporate Events

Anupam Rasayan Publishes FY26 Audited Results in Newspapers and Online
May 25, 2026
Anupam Rasayan India Ltd. has notified the stock exchanges that it has published newspaper advertisements of its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The results have been p...
Crisil lifts negative watch, reaffirms ratings on Anupam Rasayan’s Rs 1,369.82 crore bank facilities
Mar 18, 2026
Anupam Rasayan India Ltd. has disclosed that Crisil Ratings has updated its credit ratings on the company’s bank loan facilities totaling Rs 1,369.82 crore. The long-term rating has been reaffirmed at Crisil A+/Stable and the short-term rati...
Anupam Rasayan to Engage Investors at Investec India Conference 2026
Mar 6, 2026
Anupam Rasayan India Ltd. has announced that its management team will participate in the Investec India Promoter Founder Conference 2026 on March 11, 2026, at the Trident, BKC in Mumbai. The engagement will include physical one-on-one and group m...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 25, 2026